Relation between Estrogen Receptor and Malignancy of Thyroid Cancer

25Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The relationship between the histological grade of dedifferentiation of thyroid cancer and estrogen receptors (ER) was examined immunohistochemically. Thyroid cancers were from postmenopausal females of almost the same mean age (69‐73 years old) and within the same period of time (1974–1983). ER immunoreactivity located in the nucleus of the epithelium was found in all 6 well differentiated papillary cancers, and 5 of them (83.3%) showed ER‐immunoreactive (ER‐IR) cells amounting to 20 or more per visual field (x 100) under a light microscope. Of the 6 cases of poorly differentiated papillary cancer, 5 (83.3%) had 1‐19 ER‐IR cells per visual field. ER‐IR cells were negative in 5 out of 6 cases (83.3%) of anaplastic cancers. Thus, the number of ER‐IR cells tended to decrease with the degree of atypism of thyroid cancer (P < 0.001). Copyright © 1991, Wiley Blackwell. All rights reserved

Cite

CITATION STYLE

APA

Takeichi, N., Ito, H., Haruta, R., Matsuyama, T., Dohi, K., & Eiichi, E. (1991). Relation between Estrogen Receptor and Malignancy of Thyroid Cancer. Japanese Journal of Cancer Research, 82(1), 19–22. https://doi.org/10.1111/j.1349-7006.1991.tb01739.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free